Patents by Inventor Hidemi Goto

Hidemi Goto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition for preventing or treating inflammatory disease
    Patent number: 10709741
    Abstract: A composition for preventing or treating inflammatory disease and that is effective for inflammatory disease such as fulminant hepatitis and interstitial pneumonia. For such an objective, the present uses a culture supernatant obtained by culturing dental pulp stem cells as the active ingredient of the composition for preventing or treating inflammatory disease.
    Type: Grant
    Filed: February 13, 2014
    Date of Patent: July 14, 2020
    Assignee: NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY
    Inventors: Akihito Yamamoto, Minoru Ueda, Hidemi Goto, Masatoshi Ishigami, Yoshihiro Matsushita, Yoshinori Hasegawa, Naozumi Hashimoto, Hirotaka Wakayama
  • COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASE
    Publication number: 20150366917
    Abstract: A composition for preventing or treating inflammatory disease and that is effective for inflammatory disease such as fulminant hepatitis and interstitial pneumonia. For such an objective, the present uses a culture supernatant obtained by culturing dental pulp stem cells as the active ingredient of the composition for preventing or treating inflammatory disease.
    Type: Application
    Filed: February 13, 2014
    Publication date: December 24, 2015
    Inventors: Akihito YAMAMOTO, Minoru UEDA, Hidemi GOTO, Masatoshi ISHIGAMI, Yoshihiro MATSUSHITA, Yoshinori HASEGAWA, Naozumi HASHIMOTO, Hirotaka WAKAYAMA
  • Pharmaceutical composition for treatment of blood clotting disorder
    Patent number: 8217014
    Abstract: Disclosed is a pharmaceutical composition for the prevention or treatment of blood clotting disorder which can reduce a burden on a patient. The pharmaceutical composition comprises an effective amount of ribavirin or a derivative thereof or a pharmaceutically acceptable salt of ribavirin or the derivative.
    Type: Grant
    Filed: March 9, 2006
    Date of Patent: July 10, 2012
    Assignee: National University Corporation Nagoya University
    Inventors: Takashi Honda, Junki Takamatsu, Hidenori Toyoda, Koji Yamamoto, Hidemi Goto
  • USE OF RIBAVIRIN IN BLOOD COAGULATION DISORDER
    Publication number: 20110117054
    Abstract: To provide a pharmaceutical agent that is effective for the amelioration or the like of a condition where the prothrombin time is prolonged or a condition where the INR (international normalized ratio) is increased. Disclosed is a pharmaceutical agent comprising ribavirin or a derivative thereof as an active ingredient.
    Type: Application
    Filed: August 27, 2008
    Publication date: May 19, 2011
    Applicant: National University Corporation Nagoya University
    Inventors: Takashi Honda, Junki Takamatsu, Hidenori Toyoda, Koji Yamamoto, Hidemi Goto
  • Activator for Blood Coagulation Factor VII Promoter and Utilization of the Same
    Publication number: 20110045535
    Abstract: It is intended to provide an activator for blood coagulation factor VII. Ribavirin or its derivative is used as an activator for blood coagulation factor VII promoter.
    Type: Application
    Filed: August 27, 2008
    Publication date: February 24, 2011
    Applicant: National University Corporation Nagoya University
    Inventors: Takashi Honda, Junki Takamatsu, Hidenori Toyoda, Koji Yamamoto, Hidemi Goto, Tetsuhito Kojima
  • MICROTUBULE-DISRUPTNG AGENT AND CANCER CELL PROLIFERATION INHIBITOR CONTAINING THE SAME
    Publication number: 20100286283
    Abstract: The present invention provides a novel microtubule-disrupting agent, and also provides a use of the microtubule-disrupting agent. A microtubule-disrupting agent containing an ?,?-unsaturated carbonyl compound as an active ingredient is provided. Further, a cancer cell proliferation inhibitor containing the microtubule-disrupting agent is also provided. As the ?,?-unsaturated carbonyl compound, 6-shogaol is preferably used.
    Type: Application
    Filed: May 1, 2009
    Publication date: November 11, 2010
    Inventors: Kazuhiro Ishiguro, Hidemi Goto, Takafumi Ando
  • Pharmaceutical Composition For Treatment Of Blood Clotting Disorder
    Publication number: 20090232769
    Abstract: Disclosed is a pharmaceutical composition for the prevention or treatment of blood clotting disorder which can reduce a burden on a patient. The pharmaceutical composition comprises an effective amount of ribavirin or a derivative thereof or a pharmaceutically acceptable salt of ribavirin or the derivative.
    Type: Application
    Filed: March 9, 2006
    Publication date: September 17, 2009
    Applicant: National University Corporation Nagoya University
    Inventors: Takashi Honda, Junki Takamatsu, Hidenori Toyoda, Koji Yamamoto, Hidemi Goto
  • Methods for treating disorders induced by H. pylori infections and pharmaceutical compositions for the same
    Publication number: 20060194748
    Abstract: The present invention provides a pharmaceutical composition for the treatment of disorders induced, caused, and/or mediated by Helicobacter pylori infection, as well as methods of treating the same by administering the pharmaceutical composition of the present invention.
    Type: Application
    Filed: February 28, 2005
    Publication date: August 31, 2006
    Applicant: National University Corporation Nagoya University
    Inventors: Masaaki Minami, Takafumi Ando, Hidemi Goto, Michio Ohta